Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis.

TitleInactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis.
Publication TypeJournal Article
Year of Publication1999
AuthorsDiaz-Meco MT, Lallena MJ, Monjas A, Frutos S, Moscat J
JournalJ Biol Chem
Volume274
Issue28
Pagination19606-12
Date Published1999 Jul 09
ISSN0021-9258
Keywords3T3 Cells, Animals, Apoptosis, Apoptosis Regulatory Proteins, Carrier Proteins, Cell Nucleus, Cell Survival, Down-Regulation, Gene Expression Regulation, I-kappa B Kinase, Intracellular Signaling Peptides and Proteins, Mice, Mutation, NF-kappa B, Phosphorylation, Promoter Regions, Genetic, Protein Kinase C, Protein-Serine-Threonine Kinases, ras Proteins, Signal Transduction, Transcription Factor RelA, Transfection, Tumor Necrosis Factor-alpha
Abstract

Par-4 is a novel protein identified in cells undergoing apoptosis. The ability of Par-4 to promote apoptotic cell death is dependent on the binding and inactivation of the atypical protein kinases C (PKCs). This subfamily of kinases has been reported to control nuclear factor kappaB (NF-kappaB) through the regulation of the IkappaB kinase activity. NF-kappaB activation by tumor necrosis factor alpha (TNFalpha) provides a survival signal that impairs the TNFalpha-induced apoptotic response. We show here that expression of Par-4 inhibits the TNFalpha-induced nuclear translocation of p65 as well as the kappaB-dependent promoter activity. Interestingly, Par-4 expression blocks inhibitory kappaB protein (IkappaB) kinase activity, which leads to the inhibition of IkappaB phosphorylation and degradation, in a manner that is dependent on its ability to inhibit lambda/iotaPKC. Of potential functional relevance, the expression of Par-4 allows TNFalpha to induce apoptosis in NIH-3T3 cells. In addition, the down-regulation of Par-4 levels by oncogenic Ras sensitizes cells to TNFalpha-induced NF-kappaB activation.

DOI10.1074/jbc.274.28.19606
Alternate JournalJ Biol Chem
PubMed ID10391896
Related Faculty: 
Jorge Moscat, Ph.D. Maria Diaz-Meco Conde, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700